Managed Service Solution for Pathology Blood Science
A Contract Award Notice
by BARKING, HAVERING AND REDBRIDGE UNIVERSITY HOSPITALS NHS TRUST
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £7M
- Sector
- HEALTH
- Published
- 10 Mar 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Barking
1 buyer
1 supplier
- Sysmex Wymbush
Description
Managed Service Solution for Pathology Blood Sciences
Total Quantity or Scope
The Contracting Authority is not awarding a new contract. This VEAT notice is in respect of a proposed modification to the Contract. The Trust is taking up the option provided in the original contract for the provision of additional Serology and Allergen services.This VEAT notice is in respect of a proposed modification to extend the existing Managed Service Solutions for Pathology Blood Sciences contract to include additional Serology and Allergen services. The contract modification for these services will be for a period of 4 years from April 2025.See section VI.3 for further details.
Award Detail
1 | Sysmex (Wymbush)
|
Award Criteria
price | _ |
CPV Codes
- 85111800 - Pathology services
Legal Justification
The Contracting Authority is not awarding a new contract. This VEAT notice is in respect of a proposed modification to the Contract. The Trust is taking up the option provided in the original contract for the provision of additional Serology and Allergen services.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The Contracting Authority considers that the modification is permitted under each of Regulation 72(1)(a). Under the contract, the services specification references the optional pathology test services including the appropriate equipment and consumables which are available to be called off by the Contracting Authority to facilitate its healthcare and related services. This specifically includes Serology and Allergens. In addition, the charges schedule permits the Contracting Authority to add such optional test services to the scope of the Service Provider's solution deployed under the contract. It is clear that the contract's intention was to future proof the contract to the extent possible, and Serology and Allergens test services was envisaged at the time of the contract. The Contracting Authority considers that the original contract permitted this modification and envisaged these services at the time of the contract. In addition, this modification would not alter the overall nature of the contract. Therefore, the Contracting Authority’s intention to modify the contract is justified on the basis of Regulation 72(1)(a).In addition, the overall cost for including the Serology and Allergens services in the contract will not exceed 50% of the value of the original contract.
Reference
- ocds-h6vhtk-04eb26
- FTS 008581-2025